6-aminophenanthridine has been researched along with Dementias, Transmissible in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banerjee, D; Sanyal, S | 1 |
| Barbezier, N; Bidet, Y; Blondel, M; Buttstedt, A; Chartier, A; Galons, H; Schwarz, E; Simonelig, M; Voisset, C | 1 |
| Blondel, M; Saupe, SJ; Voisset, C | 1 |
2 review(s) available for 6-aminophenanthridine and Dementias, Transmissible
| Article | Year |
|---|---|
Protein folding activity of the ribosome (PFAR) -- a target for antiprion compounds.
Topics: Aminoquinolines; Binding Sites; Guanabenz; Humans; Imiquimod; Phenanthridines; Prion Diseases; Prions; Protein Folding; Ribosomes; RNA, Ribosomal | 2014 |
The various facets of the protein-folding activity of the ribosome.
Topics: Guanabenz; Molecular Chaperones; Muscular Dystrophy, Oculopharyngeal; Phenanthridines; Prion Diseases; Protein Biosynthesis; Protein Folding; Proteins; Ribosomes; RNA, Ribosomal | 2011 |
1 other study(ies) available for 6-aminophenanthridine and Dementias, Transmissible
| Article | Year |
|---|---|
Antiprion drugs 6-aminophenanthridine and guanabenz reduce PABPN1 toxicity and aggregation in oculopharyngeal muscular dystrophy.
Topics: Animals; Drosophila; Guanabenz; Larva; Muscular Dystrophy, Oculopharyngeal; Phenanthridines; Phenotype; Poly(A)-Binding Protein II; Prion Diseases; Protein Folding; RNA, Ribosomal | 2011 |